ARK Genomic Revolution ETF vs ProShares UltraPro S&P500 — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while ProShares UltraPro S&P500 trades at $154.35. Which is the better fit depends on your goals.
| ARKG | UPRO | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $44.55 | $155.10 |
52-Week Low | $24.02 | $89.29 |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →UPRO is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the S&P 500 Index. It is a tactical, high-conviction instrument designed for short-term traders to amplify bullish market moves, utilizing a daily reset mechanism that creates significant compounding effects and volatility risks over time.
Read more on UPRO →